HARVARD BIOSCIENCE, INC. Total Long-Term Debt
HARVARD BIOSCIENCE, INC. (HBIO) had Total Long-Term Debt of $36.68 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-08-11
- 2026-06-30: Long-term Debt $36.68M.
- 2026-03-31: Long-term Debt $36.21M.
- 2025-12-31: Long-term Debt $35.87M.
- 2025-09-30: Long-term Debt $33.97M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2026-06-30 | $36.68M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $36.21M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $35.87M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $33.97M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $34.90M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $36.40M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $36.96M 10-K · filed 2026-03-13 | |
| 2024-09-30 | $34.86M 10-Q · filed 2025-08-11 | $37.86M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $35.68M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $35.61M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $36.96M 10-Q · filed 2025-08-11 | $36.56M 10-K · filed 2024-03-07 |
| 2023-09-30 | $38.74M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $41.42M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $44.05M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $46.82M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $49.25M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $48.48M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $48.96M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $48.33M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $45.21M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $43.14M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $43.57M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $48.01M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $43.48M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $43.73M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $49.09M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $53.82M 10-K/A · filed 2021-03-17 | |
| 2018-12-31 | $60.80M 10-K · filed 2020-03-16 | $62.40M 10-K · filed 2019-03-18 |
| 2018-01-31 | $11.90M 10-K · filed 2018-03-16 | |
| 2017-12-31 | $11.90M 10-K · filed 2018-03-16 | |
| 2016-12-31 | $13.85M 10-K · filed 2017-03-17 | |
| 2015-12-31 | $18.90M 10-K · filed 2016-04-29 | |
| 2014-12-31 | $21.45M 10-K · filed 2015-03-12 | |
| 2013-12-31 | $24.75M 10-K · filed 2014-03-14 | |
| 2012-12-31 | $12.95M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |